Overall the study investigates organ crosstalk during exercise. More specifically, the study investigates the role of IL-6 in regulating glucose, fatty acid, and amino acid kinetics at whole body level and in skeletal muscle, liver, and brain. Furthermore, the study investigates the uptake and release of extracellular vesicles in skeletal muscle, liver, and brain in reponse to exercise.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Enrollment
30
acute exercise bout
Rigshospitalet
Copenhagen, Capital Region, Denmark
Whole body substrate kinetics.
Comparing rates of appearances (Ra) and disappearances (Rd) of glucose, glycerol, palmitate, amino acids between placebo and IL-6R ab at rest, during exercise, and recovery.
Time frame: Comparisons between placebo and IL-6R ab are done at rest (time points 255 and 270 minutes), during exercise (time points 285, 300, 315, and 330 minutes) and during recovery from exercise (time points 345, 360, and 390 minutes).
Tissue specific utilization and production of substrates.
Comparing, between placebo and IL-6Rab, by measuring in plasma, the Ra and Rd of substrates in muscle, liver, and brain at rest, during exercise, and recovery using the non-steady-state equations of Steele adapted for stable isotopes.
Time frame: Comparisons between study arms are done at rest (time points 255 and 270 minutes), during exercise (time points 285, 300, 315, and 330 minutes) and during recovery from exercise (time points 345, 360, and 390 minutes).
IL-6 regulation of protein synthesis and degradation.
Comparing differences in protein synthesis and degradation rates between placebo and IL-6Rab at rest, during exercise, and during recovery from exercise.
Time frame: Comparisons between placebo and IL-6R ab are done at rest (time points 255 and 270 minutes), during exercise (time points 285, 300, 315, and 330 minutes) and during recovery from exercise (time points 345, 360, and 390 minutes).
Number of EVs from muscle, liver, and brain.
Comparing the number of EVs deriving from skeletal muscle, liver, and brain.
Time frame: Comparisons between placebo and IL-6R ab are done before exercise (time points 255 and 270 minutes).
Size of EVs from muscle, liver, and brain.
Comparing EV size deriving from skeletal muscle, liver, and brain.
Time frame: Comparisons between placebo and IL-6R ab are done before exercise (time points 255 and 270 minutes).
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
EVs from muscle, liver, and brain.
Comparing the content of EVs deriving from skeletal muscle, liver, and brain.
Time frame: Comparisons between placebo and IL-6R ab are done before exercise (time points 255 and 270 minutes).
Influence of exercise on EV number.
Comparing the number of EVs deriving from skeletal muscle, liver, and brain in response to exercise.
Time frame: Comparisons between placebo and IL-6R ab are done throughout a 1-hour exercise bout (time points 285, 300, 315, and 330 minutes).
Influence of exercise on EV size
Comparing EV size deriving from skeletal muscle, liver, and brain in response to exercise.
Time frame: Comparisons between placebo and IL-6R ab are done throughout a 1-hour exercise bout (time points 285, 300, 315, and 330 minutes).
Influence of exercise on EV content.
Comparing the content of EVs deriving from skeletal muscle, liver, and brain in response to exercise.
Time frame: Comparisons between placebo and IL-6R ab are done throughout a 1-hour exercise bout (time points 285, 300, 315, and 330 minutes).
Tissue specific proteomic content of EVs.
Comparing differences in proteomic content of EVs from skeletal muscle, liver, and brain in response to exercise.
Time frame: Comparisons between placebo and IL-6R ab are done at the end of a 1-hour exercise bout (330 minutes).
Lactate.
Differences in plasma lactate from skeletal muscle, liver, and brain comparing placebo and IL-6R ab.
Time frame: Comparisons between placebo and IL-6R ab are done at rest (time points 255 and 270 minutes), during exercise (time points 285, 300, 315, and 330 minutes) and during recovery from exercise (time points 345, 360, and 390 minutes).
Pyruvate.
Differences in plasma pyruvate from skeletal muscle, liver, and brain comparing placebo and IL-6R ab.
Time frame: Comparisons between placebo and IL-6R ab are done at rest (time points 255 and 270 minutes), during exercise (time points 285, 300, 315, and 330 minutes) and during recovery from exercise (time points 345, 360, and 390 minutes).
Keto acids.
Differences in plasma keto acids from skeletal muscle, liver, and brain comparing placebo and IL-6R ab.
Time frame: Comparisons between placebo and IL-6R ab are done at rest (time points 255 and 270 minutes), during exercise (time points 285, 300, 315, and 330 minutes) and during recovery from exercise (time points 345, 360, and 390 minutes).
Ketone bodies.
Differences in plasma ketone bodies from skeletal muscle, liver, and brain comparing placebo and IL-6R ab.
Time frame: Comparisons between placebo and IL-6R ab are done at rest (time points 255 and 270 minutes), during exercise (time points 285, 300, 315, and 330 minutes) and during recovery from exercise (time points 345, 360, and 390 minutes).
Influence of IL-6 on fatty acid oxidation rates.
Comparing, between placebo and IL-6R ab, differences in fatty acid, e.g. palmitate oxidation rates, at whole body level and in skeletal muscle, liver, and brain.
Time frame: Comparisons between placebo and IL-6R ab are done at rest (time points 255 and 270 minutes), during exercise (time points 285, 300, 315, and 330 minutes) and during recovery from exercise (time points 345, 360, and 390 minutes).
Influence of IL-6 on insulin.
Comparing differences in plasma insulin concentrations between placebo and IL-6R ab.
Time frame: Comparisons between placebo and IL-6R ab are done at rest (time points 255 and 270 minutes), during exercise (time points 285, 300, 315, and 330 minutes) and during recovery from exercise (time points 345, 360, and 390 minutes).
Influence of IL-6 on glucagon.
Comparing differences plasma glucagon concentrations between placebo and IL-6R ab.
Time frame: Comparisons between placebo and IL-6R ab are done at rest (time points 255 and 270 minutes), during exercise (time points 285, 300, 315, and 330 minutes) and during recovery from exercise (time points 345, 360, and 390 minutes).
Influence of IL-6 on epinephrine.
Comparing differences in plasma epinephrine concentrations between placebo and IL-6R ab.
Time frame: Comparisons between placebo and IL-6R ab are done at rest (time points 255 and 270 minutes), during exercise (time points 285, 300, 315, and 330 minutes) and during recovery from exercise (time points 345, 360, and 390 minutes).
Influence of IL-6 on norepinephrine.
Comparing differences in plasma norepinephrine concentrations between placebo and IL-6R ab.
Time frame: Comparisons between placebo and IL-6R ab are done at rest (time points 255 and 270 minutes), during exercise (time points 285, 300, 315, and 330 minutes) and during recovery from exercise (time points 345, 360, and 390 minutes).
IL-6 levels.
Comparing differences in plasma IL-6 concentrations between placebo and IL-6R ab.
Time frame: Comparisons between placebo and IL-6R ab are done at rest (time points 255 and 270 minutes), during exercise (time points 285, 300, 315, and 330 minutes) and during recovery from exercise (time points 345, 360, and 390 minutes).
Influence of IL-6 on substrate usage.
Differences in respiratory exchange ratio comparing placebo and IL-6R ab.
Time frame: Comparisons between placebo and IL-6R ab are done at rest (time points 255 and 270 minutes), during exercise (time points 285, 300, 315, and 330 minutes) and during recovery from exercise (time points 345, 360, and 390 minutes).
Influence of IL-6 on perceived exertion.
Differences in rate of perceived exertion during exercise comparing placebo and IL-6R ab.
Time frame: Comparisons between placebo and IL-6R ab are done during exercise (time points 285, 300, 315, and 330 minutes).